• Tags: dry eye
Bausch + Lomb launches Blink Triple Care PF eye drops
Products

Bausch + Lomb launches Blink Triple Care PF eye drops

Preservative-free lubricant features hyaluronic acid and castor oil to offer a 3-in-1 extended dry eye symptom relief for up to 10 hours.
Upsher-Smith launches Restasis generic to US market
Products

Upsher-Smith launches Restasis generic to US market

Latest generic version of Allergan’s Restasis will be available as single-use vials in two packaging options.
Rain Eyecare launches dedicated dry eye telehealth platform
Products

Rain Eyecare launches dedicated dry eye telehealth platform

Direct-to-consumer service offers personalized, prescription-based treatment plans from licensed providers—including a generic Restasis option.
B+L Vision Care Summit spotlights contact lens and technology advancements
Events

B+L Vision Care Summit spotlights contact lens and technology advancements

Clinicians share insights on dry eye care, contact lens adoption, and patient-centered treatment approaches.
Could human breast milk treat dry eye disease?
Research

Could human breast milk treat dry eye disease?

Narrative review traces ophthalmic uses of human milk back to anciant Egyptian papyrus, finding the biology behind it might hold up.
Vitamin D deficiency leads to increased dry eye risk
Research

Vitamin D deficiency leads to increased dry eye risk

Study findings suggest patients with low Vitamin D levels may face a higher likelihood of developing DED.
B+L Consumer Summit highlights OTC integration as key to managing ocular surface health
Events

B+L Consumer Summit highlights OTC integration as key to managing ocular surface health

Clinicians emphasize over-the-counter options as a first-line treatment for ocular surface disease during Bausch + Lomb’s one-day consumer summit.
Dry eye may indicate early signs of autoimmune disease
Research

Dry eye may indicate early signs of autoimmune disease

Study findings suggest ocular surface symptoms may precede systemic autoimmune diagnosis by several years.
Dry Eye Institute to host immersive education retreat in Dublin
Events

Dry Eye Institute to host immersive education retreat in Dublin

Dry eye education program's first-ever global expansion offers four days of customized, interactive learning and COPE-accredited CE.
FDA issues third CRL to Aldeyra, rejecting reproxalap NDA
Pipeline

FDA issues third CRL to Aldeyra, rejecting reproxalap NDA

Agency notes a lack of substantial evidence, failure to demonstrate efficacy, and inconsistent study results in latest dismissal of the DED eye drop.
TearRestore launches OneDrop for daily dry eye care
Products

TearRestore launches OneDrop for daily dry eye care

Artificial tear is formulated with a preservative-free-based nanoemulsion engineered to mimic and reinforce all three layers of the natural tear film.
CSI Dry Eye Innovations unveils new branding and software patent
Business

CSI Dry Eye Innovations unveils new branding and software patent

Rebrand paves way for potential future dry eye product launches to join its flagship, AI-based program: CSI Dry Eye Software.
Novartis's ianalumab earns FDA Breakthrough Therapy designation for Sjögren’s disease
Pipeline

Novartis's ianalumab earns FDA Breakthrough Therapy designation for Sjögren’s disease

Fully human monoclonal antibody is delivered as a monthly subcutaneous injection; company plans to submit for global approval in early 2026.
OCuSOFT launches Retaine Omega Forte for dry eye
Products

OCuSOFT launches Retaine Omega Forte for dry eye

New nutritional supplement offers a daily dose of omega-3 essential fatty acids.
Registration now open for Eyes On Dry Eye 2026
Events

Registration now open for Eyes On Dry Eye 2026

Largest virtual dry eye event of the year offers up to 7 hours of free CE from leading clinical experts.
Focus Vitamins launches PF artificial tears for dry eye
Products

Focus Vitamins launches PF artificial tears for dry eye

Manufactured by cGMP- and NSF-certified suppliers, Focus Tears PF Eye Drops are formulated with CMC sodium 0.5% to offer temporary ocular relief.
FDA extends reproxalap's PDUFA to March 2026
Pipeline

FDA extends reproxalap's PDUFA to March 2026

Updated target action date applies to Aldeyra’s third NDA submission of the investigational DED eye drop.
Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief
Products

Scope's OPTASE HYLO Forte Dry Eye Drops offer long-lasting symptom relief

Clinical experts share OD-MD insights into the advanced artificial tears’ hydrating PF formulation with active glycerin and hyaluronic acid. 
Azura gets positive FDA feedback on NDA submission for MGD ointment
Pipeline

Azura gets positive FDA feedback on NDA submission for MGD ointment

Positive pre-NDA meeting for selenium sulfide ointment precedes planned phase 3 data release in Q1 2026 and regulatory submission in H2 2026. 
Amneal receives FDA approval for Restasis generic
Products

Amneal receives FDA approval for Restasis generic

Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.